Back
Nomura Tax-Free USA Short Term ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
52
STAX
Nomura Tax-Free USA Short Term ETF
Last Price:
$25.48
Seasonality Move:
0.73%
Buy
75
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.02
Seasonality Move:
9.28%
Buy
52
Nomura Tax-Free USA Short Term ETF (STAX)
is a Buy
Is Nomura Tax-Free USA Short Term ETF a Buy, Sell or Hold?
-
The current Nomura Tax-Free USA Short Term ETF [STAX] share price is $25.48. The Score for STAX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
STAX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.10. The Score for CDTX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
STAX Stock Price Chart
What is Nomura Tax-Free USA Short Term ETF's stock price today?
-
The Nomura Tax-Free USA Short Term ETF share price today is $25.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STAX is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.10The current trend is moderately bullish and CDTX is experiencing slight selling pressure.
STAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.12 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.45 - 25.49) | Buy |
| Bollinger Bands (100): | (25.46 - 25.6) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.3 | Buy |
| Relative Strength Index (14 RSI): | 84.85 | Buy |
| Chaikin Money Flow: | -80058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (159.96 - 243.16) | Buy |
| Bollinger Bands (100): | (52.17 - 169.49) | Buy |
STAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.46 | Buy |
| 20-day SMA: | 25.47 | Buy |
| 50-day SMA: | 25.5 | Sell |
| 200-day SMA: | 25.4 | Buy |
| 8-day EMA: | 25.47 | Buy |
| 20-day EMA: | 25.47 | Buy |
| 50-day EMA: | 24.97 | Buy |
| 200-day EMA: | 15.85 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.22 | Sell |
| 20-day SMA: | 219.81 | Buy |
| 50-day SMA: | 152.4 | Buy |
| 200-day SMA: | 69.82 | Buy |
| 8-day EMA: | 219.59 | Buy |
| 20-day EMA: | 205.67 | Buy |
| 50-day EMA: | 165.16 | Buy |
| 200-day EMA: | 89.39 | Buy |
Nomura Tax-Free USA Short Term ETF Earnings Growth & STAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Nomura Tax-Free USA Short Term ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||